Mom & Baby well-being → healthy population futures.  The vision of the company is to make this a reality.

We are developing the first digital therapeutic for postpartum depression. The goal is to improve care outcomes and effectiveness of treatment for postpartum mothers and opioid addicted mothers suffering from anxiety/depression as a dual comorbidity, a key cause of overdose.  Join us and support our vision.